Keratinocyte cancer and its precursors in organ transplant patients
- PMID: 25561206
- DOI: 10.1159/000366535
Keratinocyte cancer and its precursors in organ transplant patients
Abstract
Organ transplant recipients (OTRs) have a 65- to 250-fold increased risk of the development of cutaneous squamous cell carcinoma in the wake of immunosuppression. The combination of ultraviolet light and properties of immunosuppressive drugs potentiate skin cancer formation. Due to decreased peritumoral inflammation, the thickness and invasion of epithelial skin lesions are often underestimated clinically. Rapid tumor progression and aggressive tumor behaviors occur frequently in the OTR population. Tenderness and pain in a skin lesion may indicate its potential invasion beyond the basal membrane and the need for surgical removal. All patients should receive extensive education on ultraviolet avoidance and protection. In particular, a preventive and aggressive treatment of actinic keratosis in areas of field cancerization is recommended to cut down on the high morbidity and avoid the mortality associated with actinic keratosis and invasive squamous cell carcinoma in OTRs.
© 2015 S. Karger AG, Basel.
Similar articles
-
[Organ transplant recipients need intensive control and treatment of skin cancer].Ugeskr Laeger. 2013 May 13;175(20):1408-11. Ugeskr Laeger. 2013. PMID: 23663395 Review. Danish.
-
Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study.Br J Dermatol. 2009 Nov;161 Suppl 3:78-84. doi: 10.1111/j.1365-2133.2009.09453.x. Br J Dermatol. 2009. PMID: 19775361
-
Therapeutic options to decrease actinic keratosis and squamous cell carcinoma incidence and progression in solid organ transplant recipients: a practical approach.Dermatol Surg. 2012 Oct;38(10):1604-21. doi: 10.1111/j.1524-4725.2012.02452.x. Epub 2012 May 30. Dermatol Surg. 2012. PMID: 22646842 Review.
-
Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients.N Engl J Med. 2023 Mar 2;388(9):804-812. doi: 10.1056/NEJMoa2203086. N Engl J Med. 2023. PMID: 36856616 Clinical Trial.
-
Organ transplantation and skin cancer: basic problems and new perspectives.Exp Dermatol. 2010 Jun;19(6):473-82. doi: 10.1111/j.1600-0625.2010.01086.x. Epub 2010 May 7. Exp Dermatol. 2010. PMID: 20482618 Review.
Cited by
-
Voriconazole enhances UV-induced DNA damage by inhibiting catalase and promoting oxidative stress.Exp Dermatol. 2020 Jan;29(1):29-38. doi: 10.1111/exd.14038. Epub 2019 Oct 29. Exp Dermatol. 2020. PMID: 31519066 Free PMC article.
-
The Role of Beta HPV Types and HPV-Associated Inflammatory Processes in Cutaneous Squamous Cell Carcinoma.J Immunol Res. 2020 Apr 6;2020:5701639. doi: 10.1155/2020/5701639. eCollection 2020. J Immunol Res. 2020. PMID: 32322596 Free PMC article. Review.
-
Genome-wide association study of actinic keratosis identifies new susceptibility loci implicated in pigmentation and immune regulation pathways.Commun Biol. 2022 Apr 21;5(1):386. doi: 10.1038/s42003-022-03301-3. Commun Biol. 2022. PMID: 35449187 Free PMC article.
-
The ARE-binding protein Tristetraprolin (TTP) is a novel target and mediator of calcineurin tumor suppressing function in the skin.PLoS Genet. 2018 May 3;14(5):e1007366. doi: 10.1371/journal.pgen.1007366. eCollection 2018 May. PLoS Genet. 2018. PMID: 29723192 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical